Kjellman B F, Ljunggren J G, Beck-Friis J, Wetterberg L
Psychiatry Res. 1985 Apr;14(4):353-63. doi: 10.1016/0165-1781(85)90103-9.
The thyrotropin-releasing hormone (TRH) test was studied in 32 patients with acute major depressive disorder, 16 patients with recurrent unipolar (n = 8) or bipolar (n = 8) affective disorder in remission, and 22 healthy control subjects. Twenty-six of the 32 acutely ill patients were also studied when in remission. Outcome in these patients was correlated to serum levels of triiodothyronine (T3), 3,3',5'triiodothyronine (reverse T3), thyroxine (T4), thyroid-stimulating hormone (TSH), prolactin (PRL), melatonin, dexamethasone suppression test (DST) results, and clinical symptoms assessed by the Comprehensive Psychopathological Rating Scale (CPRS). The TSH response to TRH (delta TSH) was decreased in the acutely ill patients, but no difference was found between patients in remission and controls. The delta TSH was correlated to TSH but not to T3 and T4 levels in both acutely ill and control subjects. In the acutely ill group, delta TSH did not distinguish between patients with normal and abnormal DST results. Thus, abnormalities in the hypothalamic-pituitary-thyroid (HPT) axis are not correlated to abnormalities in the hypothalamic-pituitary-adrenal (HPA) axis. Moreover, delta TSH did not differentiate between melancholic (DSM-III) and nonmelancholic patients or between patients with primary and secondary depression. No correlation was found between delta TSH and CPRS scores. Patients with observable agitation greater than 0.25 points (item range 0-3) had higher levels of delta TSH than patients with lower levels. No significant correlation was found between delta TSH and seven specific symptom clusters on the CPRS. However, there was a possible relation between low delta TSH and violent suicide attempts or suicide. PRL levels did not distinguish acutely ill patients from controls. Finally, there was no significant regression between delta TSH and melatonin levels. The decrease in delta TSH seen in the acutely ill patients was too small to be of diagnostic value as a laboratory measure differentiating acutely ill and healthy subjects. The mechanism underlying the HPT alterations in acute major depressive disorder may be a desensitization of the TRH receptor in the thyrotrophs secondary to an increased endogenous TRH stimulation.
对32例急性重度抑郁症患者、16例缓解期复发性单相(n = 8)或双相(n = 8)情感障碍患者以及22名健康对照者进行了促甲状腺激素释放激素(TRH)试验。32例急性病患者中有26例在缓解期也进行了研究。这些患者的结果与血清三碘甲状腺原氨酸(T3)、3,3',5'-三碘甲状腺原氨酸(反T3)、甲状腺素(T4)、促甲状腺激素(TSH)、催乳素(PRL)、褪黑素水平、地塞米松抑制试验(DST)结果以及综合精神病理学评定量表(CPRS)评估的临床症状相关。急性病患者对TRH的TSH反应(ΔTSH)降低,但缓解期患者与对照组之间未发现差异。在急性病患者和对照者中,ΔTSH与TSH相关,但与T3和T4水平无关。在急性病组中,ΔTSH无法区分DST结果正常和异常的患者。因此,下丘脑-垂体-甲状腺(HPT)轴异常与下丘脑-垂体-肾上腺(HPA)轴异常无关。此外,ΔTSH无法区分忧郁症(DSM-III)患者和非忧郁症患者,也无法区分原发性和继发性抑郁症患者。未发现ΔTSH与CPRS评分之间存在相关性。可观察到的激越程度大于0.25分(项目范围0 - 3)的患者的ΔTSH水平高于激越程度较低的患者。未发现ΔTSH与CPRS上的七个特定症状群之间存在显著相关性。然而,低ΔTSH与暴力自杀企图或自杀之间可能存在关联。PRL水平无法区分急性病患者和对照者。最后,ΔTSH与褪黑素水平之间无显著回归关系。急性病患者中观察到的ΔTSH降低幅度太小,作为区分急性病患者和健康受试者的实验室指标无诊断价值。急性重度抑郁症中HPT改变的潜在机制可能是由于内源性TRH刺激增加,导致促甲状腺细胞中TRH受体脱敏。